Enerpac Tool(US:EPAC)2025-12-18 13:30Financial Performance - Enerpac Tool Group's Q1 FY26 net sales were $144 million, a decrease of 0.7% compared to $145 million in Q1 FY25[8] - Organic sales decreased by 2.4% overall[8] - Adjusted EBITDA was $32.4 million, a 5.7% decrease compared to $34.3 million in Q1 FY25[13] - Adjusted EPS was $0.36, a 10% decrease compared to $0.40 in Q1 FY25[13] - Gross margin was 50.7%, a decrease of 70 basis points year-over-year[13] - Adjusted SG&A was 29.8% of sales, an increase of 80 basis points year-over-year[13] Segment Performance - IT&S product sales grew organically by 4%[6,8] - IT&S service sales decreased organically by 26.3%[8] - Cortland Biomedical sales grew organically by 27.3%[8] Regional Performance (IT&S) - Americas region experienced 5% organic growth[9] - EMEA region experienced a 10% organic decline[9] - APAC region experienced an 8% organic decline[9] FY26 Guidance - Net sales are projected to be between $635 million and $655 million, with organic growth of approximately 1-4%[22] - Adjusted EBITDA is expected to be between $158 million and $168 million[23] - Adjusted EPS is projected to be between $1.85 and $2.00[23]